Two Dana-Farber Cancer Institute faculty elected to American Academy of Arts and Sciences

Posted date

Benjamin Ebert, MD, PhD, chair of medical oncology at Dana-Farber and the George P. Canellos, MD, and Jean S. Canellos professor of medicine at Harvard Medical School; and David Pellman, MD,  Margaret M. Dyson professor of pediatric oncology and a professor of Cell Biology at Harvard Medical School, have been elected to the American Academy of Arts and Sciences.

Both are included in the biological sciences group. Ebert is in the Medical Sciences section and Pellman is in Cellular and Developmental Biology section.

The nearly 270 members elected in 2023 are drawn from academia, the arts, industry, policy, research, and science, and include more than 40 International Honorary Members (IHM) from 23 countries.

When announcing this year’s new members, Academy President David W. Oxtoby said, “With the election of these members, the Academy is honoring excellence, innovation, and leadership and recognizing a broad array of stellar accomplishments. We hope every new member celebrates this achievement and joins our work advancing the common good.”

This year’s election of new members to the American Academy of Arts and Sciences maintains a commitment to honoring excellence that began more than 240 years ago. In 1780, the Academy’s founders—including John Adams and John Hancock—envisioned an organization that would recognize accomplished individuals and engage them in addressing the greatest challenges facing the young nation. The first members elected to the Academy in 1781 included Benjamin Franklin and George Washington.

Today, the Academy continues to be both an honorary society—electing new members from the non-profit, private, and public sectors—and an independent policy organization with initiatives in the arts, democracy, education, global affairs, and science.

The full list of members elected in 2023 can be viewed here.


Related Doctors and Researchers

Media Contacts

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email

The Media Team cannot respond to patient inquiries. For more information, please see Contact Us.